These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 10070810)

  • 1. Inflammation, atherosclerosis, and cardiovascular risk: an epidemiologic view.
    Ridker PM
    Blood Coagul Fibrinolysis; 1999 Feb; 10 Suppl 1():S9-12. PubMed ID: 10070810
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Rheumatoid arthritis, inflammation, and atherosclerosis].
    Hürlimann D; Enseleit F; Ruschitzka F
    Herz; 2004 Dec; 29(8):760-8. PubMed ID: 15599672
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HMG-CoA reductase inhibition: anti-inflammatory effects beyond lipid lowering?
    März W; Köenig W
    J Cardiovasc Risk; 2003 Jun; 10(3):169-79. PubMed ID: 12775949
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Atherogenesis: the role of inflammation and infection.
    Mahmoudi M; Curzen N; Gallagher PJ
    Histopathology; 2007 Apr; 50(5):535-46. PubMed ID: 17394488
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Atherosclerosis and arteriitis: implications for therapy of cardiovascular disease].
    Galle J
    Herz; 2004 Feb; 29(1):4-11. PubMed ID: 14968336
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inflammation, immunity, and HMG-CoA reductase inhibitors: statins as antiinflammatory agents?
    Schönbeck U; Libby P
    Circulation; 2004 Jun; 109(21 Suppl 1):II18-26. PubMed ID: 15173059
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inflammation and atherosclerosis.
    Steffens S; Mach F
    Herz; 2004 Dec; 29(8):741-8. PubMed ID: 15599670
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The pravastatin inflammation CRP evaluation (PRINCE): rationale and design.
    Albert MA; Staggers J; Chew P; Ridker PM;
    Am Heart J; 2001 Jun; 141(6):893-8. PubMed ID: 11376301
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cardiovascular disease: C-reactive protein and the inflammatory disease paradigm: HMG-CoA reductase inhibitors, alpha-tocopherol, red yeast rice, and olive oil polyphenols. A review of the literature.
    Patrick L; Uzick M
    Altern Med Rev; 2001 Jun; 6(3):248-71. PubMed ID: 11410071
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Low-density lipoprotein triglycerides associated with low-grade systemic inflammation, adhesion molecules, and angiographic coronary artery disease: the Ludwigshafen Risk and Cardiovascular Health study.
    März W; Scharnagl H; Winkler K; Tiran A; Nauck M; Boehm BO; Winkelmann BR
    Circulation; 2004 Nov; 110(19):3068-74. PubMed ID: 15505088
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of inflammation in acute coronary syndromes: review of the literature.
    Elhajj II; Haydar AA; Hujairi NM; Goldsmith DJ
    J Med Liban; 2004; 52(2):96-102. PubMed ID: 15884689
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biomarkers of outcome from cardiovascular disease.
    Khuseyinova N; Koenig W
    Curr Opin Crit Care; 2006 Oct; 12(5):412-9. PubMed ID: 16943718
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inflammation in atherosclerosis and implications for therapy.
    Paoletti R; Gotto AM; Hajjar DP
    Circulation; 2004 Jun; 109(23 Suppl 1):III20-6. PubMed ID: 15198962
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Markers of inflammation and coronary artery disease.
    Saadeddin SM; Habbab MA; Ferns GA
    Med Sci Monit; 2002 Jan; 8(1):RA5-12. PubMed ID: 11782689
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Contributions of depressive mood and circulating inflammatory markers to coronary heart disease in healthy European men: the Prospective Epidemiological Study of Myocardial Infarction (PRIME).
    Empana JP; Sykes DH; Luc G; Juhan-Vague I; Arveiler D; Ferrieres J; Amouyel P; Bingham A; Montaye M; Ruidavets JB; Haas B; Evans A; Jouven X; Ducimetiere P;
    Circulation; 2005 May; 111(18):2299-305. PubMed ID: 15867179
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of inflammation in atherothrombosis: current and future strategies of medical treatment.
    Geisler T; Bhatt DL
    Med Sci Monit; 2004 Dec; 10(12):RA308-16. PubMed ID: 15567994
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The time for cardiovascular inflammation reduction trials has arrived: how low to go for hsCRP?
    Ridker PM
    Arterioscler Thromb Vasc Biol; 2008 Jul; 28(7):1222-4. PubMed ID: 18565847
    [No Abstract]   [Full Text] [Related]  

  • 18. Anti-inflammatory drugs and atherosclerosis.
    Moubayed SP; Heinonen TM; Tardif JC
    Curr Opin Lipidol; 2007 Dec; 18(6):638-44. PubMed ID: 17993809
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Therapeutic elevation of HDL-cholesterol to prevent atherosclerosis and coronary heart disease.
    Chapman MJ
    Pharmacol Ther; 2006 Sep; 111(3):893-908. PubMed ID: 16574234
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inflammation in atherosclerosis and psoriasis: common pathogenic mechanisms and the potential for an integrated treatment approach.
    Späh F
    Br J Dermatol; 2008 Aug; 159 Suppl 2():10-7. PubMed ID: 18700910
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.